Global diversity within and between human herpesvirus 1 and 2 glycoproteins

Journal of Virology

Volumn 89, Issue 16, 2015, Pages 8206-8218

  Lamers, Susanna L ^a   Newman, Ruchi M ^b   Laeyendecker, Oliver ^c   Tobian, Aaron A R ^c   Colgrove, Robert C ^d,e   Ray, Stuart C ^f   Koelle, David M ^g,h   Cohen, Jeffrey ^c   Knipe, David M ^d   Quinn, Thomas C ^c,e  

^a BIOINFOEXPERTS LLC   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MOUNT AUBURN HOSPITAL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN D; GLYCOPROTEIN E; GLYCOPROTEIN H; GLYCOPROTEIN I; GLYCOPROTEIN J; GLYCOPROTEIN K; GLYCOPROTEIN L; GLYCOPROTEIN M; GLYCOPROTEIN N; PROTEIN C; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN C; VIRUS GLYCOPROTEIN G; GLYCOPROTEIN; VIRAL PROTEIN;

AFRICA; AMINO ACID SUBSTITUTION; ARTICLE; ASIA; CLADISTICS; CONSENSUS SEQUENCE; CONTROLLED STUDY; EUROPE; GENE CLUSTER; GENETIC RECOMBINATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; MICROBIAL DIVERSITY; NONHUMAN; NORTH AMERICA; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SOUTH AFRICAN; VIRUS DIAGNOSIS; VIRUS ISOLATION; ANIMAL; HUMAN; METABOLISM;

DNA VIRUSES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

ANIMALS; GLYCOPROTEINS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; PHYLOGENY; VIRAL PROTEINS;

EID: 84938099464     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01302-15     Document Type: Article

References (61)

1. Whitley R, Roizman B, Knipe D, Knipe D, Howley P (ed). 2013. Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Tobian AA, Charvat B, Ssempijja V, Kigozi G, Serwadda D, Makumbi F, Iga B, Laeyendecker O, Riedesel M, Oliver A, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH, Quinn TC. 2009. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 199:945-949. http://dx.doi.org/10.1086/597074.
3. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 15:886-892. http://dx.doi.org/10.1038/nm.2006.
4. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaugnessy M, Corey L. 1998. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 280:61-66. http://dx.doi.org/10.1001/jama.280.1.61.
5. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Jr, Self SG, Corey L. 2008. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 3:e2230. http://dx.doi.org/10.1371/journal.pone.0002230.
6. Szpara ML, Gatherer D, Ochoa A, Greenbaum B, Dolan A, Bowden RJ, Enquist LW, Legendre M, Davison AJ. 2014. Evolution and diversity in human herpes simplex virus genomes. J Virol 88:1209-1227. http://dx.doi.org/10.1128/JVI.01987-13.
7. Newman RM, Lamers SL, Weiner B, Ray SC, Colgrove RC, Diaz F, Jing L, Wang K, Saif S, Young S, Henn M, Laeyendecker O, Tobian AAR, Cohen JI, Koelle DM, Quinn TC, Knipe DM. 2015. Genome sequencing and analysis of geographically diverse clinical isolates of herpes simplex virus 2. J Virol 89:8219-8232. http://dx.doi.org/10.1128/JVI.01303-15.
8. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. 1998. The genome sequence of herpes simplex virus type 2. J Virol 72:2010-2021.
9. Salemi M, Vandamme A-M, Lemey P. 2009. The phylogenetic hand-book: a practical approach to phylogenetic analysis and hypothesis testing, 2nd ed. Cambridge University Press, Cambridge, United Kingdom.
10. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol 82:8605-8618. http://dx.doi.org/10.1128/JVI.00904-08.
11. Jons A, Granzow H, Kuchling R, Mettenleiter TC. 1996. The UL49.5 gene of pseudorabies virus codes for an O-glycosylated structural protein of the viral envelope. J Virol 70:1237-1241.
12. Koyano S, Mar EC, Stamey FR, Inoue N. 2003. Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion. J Gen Virol 84:1485-1491. http://dx.doi.org/10.1099/vir.0.18941-0.
13. Haarr L, Skulstad S. 1994. The herpes simplex virus type 1 particle: structure and molecular functions. APMIS 102:321-346. http://dx.doi.org/10.1111/j.1699-0463.1994.tb04882.x.
14. Norberg P, Bergstrom T, Rekabdar E, Lindh M, Liljeqvist JA. 2004. Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol 78:10755-10764. http://dx.doi.org/10.1128/JVI.78.19.10755-10764.2004.
15. Kolb AW, Adams M, Cabot EL, Craven M, Brandt CR. 2011. Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distribution. Invest Ophthalmol Vis Sci 52:9061-9073. http://dx.doi.org/10.1167/iovs.11-7812.
16. Bowden R, Sakaoka H, Donnelly P, Ward R. 2004. High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection. Infect Genet Evol 4:115-123. http://dx.doi.org/10.1016/j.meegid.2004.01.009.
17. Liljeqvist JA, Tunback P, Norberg P. 2009. Asymptomatically shed recombinant herpes simplex virus type 1 strains detected in saliva. J Gen Virol 90:559-566. http://dx.doi.org/10.1099/vir.0.007070-0.
18. Rose L, Crowley B. 2013. Molecular characterization of clinical isolates of herpes simplex virus type 1 collected in a tertiary-care hospital in Dublin, Ireland. J Med Virol 85:839-844. http://dx.doi.org/10.1002/jmv.23541.
19. Harishankar A, Jambulingam M, Gowrishankar R, Venkatachalam A, Vetrivel U, Ravichandran S, Yesupadam SM, Madhavan HN. 2012. Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification. Virol J 9:65. http://dx.doi.org/10.1186/1743-422X-9-65.
20. Norberg P, Kasubi MJ, Haarr L, Bergstrom T, Liljeqvist JA. 2007. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol 81:13158-13167. http://dx.doi.org/10.1128/JVI.01310-07.
21. Schmidt-Chanasit J, Bialonski A, Heinemann P, Ulrich RG, Gunther S, Rabenau HF, Doerr HW. 2010. A 12-year molecular survey of clinical herpes simplex virus type 2 isolates demonstrates the circulation of cladeA and B strains in Germany. J Clin Virol 48:208-211. http://dx.doi.org/10.1016/j.jcv.2010.04.009.
22. Colgrove R, Diaz F, Newman R, Saif S, Shea T, Young S, Henn M, Knipe DM. 2014. Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain. Virology 450-451:140-145. http://dx.doi.org/10.1016/j.virol.2013.12.014.
23. Summerton J, Riedesel M, Laeyendecker O, Gaydos C, Maldeis NE, Hardick A, Morrow RA, Quinn TC. 2007. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics. Clin Vaccine Immunol 14:1545-1549. http://dx.doi.org/10.1128/CVI.00120-07.
24. Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Morrow RA, Serwadda D, Gray RH, Quinn TC. 2008. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol 15:888-890. http://dx.doi.org/10.1128/CVI.00453-07.
25. Hogrefe W, Su X, Song J, Ashley R, Kong L. 2002. Detection of herpes simplex virus type 2-specific immunoglobulinGantibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol 40:3635-3640. http://dx.doi.org/10.1128/JCM.40.10.3635-3640.2002.
26. Smith JS, Bailey RC, Westreich DJ, Maclean I, Agot K, Ndinya-Achola JO, Hogrefe W, Morrow RA, Moses S. 2009. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing. Sex Transm Infect 85:92-96. http://dx.doi.org/10.1136/sti.2008.031815.
27. van Dyck E, Buve A, Weiss HA, Glynn JR, Brown DW, De Deken B, Parry J, Hayes RJ. 2004. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 42:2961-2965. http://dx.doi.org/10.1128/JCM.42.7.2961-2965.2004.
28. Laeyendecker O, Henson C, Gray RH, Nguyen RH, Horne BJ, Wawer MJ, Serwadda D, Kiwanuka N, Morrow RA, Hogrefe W, Quinn TC. 2004. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Microbiol 42:1794-1796. http://dx.doi.org/10.1128/JCM.42.4.1794-1796.2004.
29. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599. http://dx.doi.org/10.1093/molbev/msm092.
30. Tamura K. 1992. Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases. Mol Biol Evol 9:678-687.
31. Nei M, Gojobori T. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418-426.
32. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. 2010. RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26:2462-2463. http://dx.doi.org/10.1093/bioinformatics/btq467.
33. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD. 2006. GARD: a genetic algorithm for recombination detection. Bioinformatics 22:3096-3098. http://dx.doi.org/10.1093/bioinformatics/btl474.
34. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 23:254-267.
35. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
36. Salminen MO, Carr JK, Burke DS, McCutchan FE. 1995. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11:1423-1425. http://dx.doi.org/10.1089/aid.1995.11.1423.
37. Suzuki Y, Nei M. 2001. Reliabilities of parsimony-based and likelihoodbased methods for detecting positive selection at single amino acid sites. Mol Biol Evol 18:2179-2185. http://dx.doi.org/10.1093/oxfordjournals.molbev.a003764.
38. Suzuki Y, Nei M. 2002. Simulation study of the reliability and robustness of the statistical methods for detecting positive selection at single amino acid sites. Mol Biol Evol 19:1865-1869. http://dx.doi.org/10.1093/oxfordjournals.molbev.a004010.
39. Suzuki Y, Nei M. 2004. False-positive selection identified by ML-based methods: examples from the Sig1 gene of the diatom Thalassiosira weissflogii and the tax gene of a human T-cell lymphotropic virus. Mol Biol Evol 21:914-921. http://dx.doi.org/10.1093/molbev/msh098.
40. PondSL, Frost SD, Muse SV. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676-679. http://dx.doi.org/10.1093/bioinformatics/bti079.
41. Kosakovsky Pond SL, Frost SD. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22:1208-1222. http://dx.doi.org/10.1093/molbev/msi105.
42. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ. 2006. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2:e62. http://dx.doi.org/10.1371/journal.pcbi.0020062.
43. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. 2012. Detecting individual sites subject to episodic diversifying selection. PLoS Genet 8:e1002764. http://dx.doi.org/10.1371/journal.pgen.1002764.
44. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K. 2013. FUBAR: a fast, unconstrained Bayesian approximation for inferring selection. Mol Biol Evol 30:1196-1205. http://dx.doi.org/10.1093/molbev/mst030.
45. Zuckerkandl E, Pauling L. 1965. Evolutionary divergence and convergence in proteins. Academic Press, New York, NY.
46. Ragonnet-Cronin M, Hodcroft E, Hue S, Fearnhill E, Delpech V, Brown AJ, Lycett S. 2013. Automated analysis of phylogenetic clusters. BMC Bioinformatics 14:317. http://dx.doi.org/10.1186/1471-2105-14-317.
47. Korber B, Myers G. 1992. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 8:1549-1560. http://dx.doi.org/10.1089/aid.1992.8.1549.
48. Martin D, Rybicki E. 2000. RDP: detection of recombination amongst aligned sequences. Bioinformatics 16:562-563. http://dx.doi.org/10.1093/bioinformatics/16.6.562.
49. Grabowska A, Jameson C, Laing P, Jeansson S, Sjogren-Jansson E, Taylor J, Cunningham A, Irving WL. 1999. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol 80:1789-1798.
50. Wertheim JO, Smith MD, Smith DM, Scheffler K, Kosakovsky Pond SL. 2014. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol Biol Evol 31:2356-2364. http://dx.doi.org/10.1093/molbev/msu185.
51. Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RL, Ewell MG, Stokes-Riner A, Dubin G, Heineman TC, Schulte JM, Deal CD. 2012. Efficacy results of a trial of a herpes simplex vaccine.NEngl J Med 366:34-43. http://dx.doi.org/10.1056/NEJMoa1103151.
52. Dutton JL, Li B, Woo WP, Marshak JO, Xu Y, Huang ML, Dong L, Frazer IH, Koelle DM. 2013. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice. PLoS One 8:e76407. http://dx.doi.org/10.1371/journal.pone.0076407.
53. Jones CA, Cunningham AL. 2003. Development of prophylactic vaccines for genital and neonatal herpes. Expert Rev Vaccines 2:541-549. http://dx.doi.org/10.1586/14760584.2.4.541.
54. Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI. 2009. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis 200: 1088-1095. http://dx.doi.org/10.1086/605645.
55. Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD. 2014. Correlate of immune protection against HSV-1 genital disease in vaccinated women. J Infect Dis 209:828-836. http://dx.doi.org/10.1093/infdis/jit651.
56. Long D, Skoberne M, Gierahn TM, Larson S, Price JA, Clemens V, Baccari AE, Cohane KP, Garvie D, Siber GR, Flechtner JB. 2014. Identification of novel virus-specific antigens by CD4(+) and CD8(+) T cells from asymptomatic HSV-2 seropositive and seronegative donors. Virology 464-465:296-311. http://dx.doi.org/10.1016/j.virol.2014.07.018.
57. Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH. 2014. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans. J Virol 88:12612-12622. http://dx.doi.org/10.1128/JVI.01930-14.
58. McGeoch DJ, Cook S, Dolan A, Jamieson FE, Telford EA. 1995. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol 247:443-458. http://dx.doi.org/10.1006/jmbi.1995.0152.
59. McGeoch DJ, Cook S. 1994. Molecular phylogeny of the Alphaherpesvirinae subfamily and a proposed evolutionary timescale. J Mol Biol 238: 9-22. http://dx.doi.org/10.1006/jmbi.1994.1264.
60. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St Louis ME. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337:1105-1111. http://dx.doi.org/10.1056/NEJM199710163371601.
61. Nahmias AJ, Lee FK, Beckman-Nahmias S. 1990. Sero-epidemiological and-sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 69:19-36.